newsfilter
← Latest News
PR Newswire·

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jideytro (zidesamtinib), a ROS1 selective inhibitor,...